Clinical Relevance and Plasmid Dynamics of Mcr-1-positive Escherichia Coli in China: a Multicentre Case-Control and Molecular Epidemiological Study
Yan Jiang,Ying Zhang,Jun Lu,Qihui Wang,Yushan Cui,Yanfei Wang,Jingjing Quan,Dongdong Zhao,Xiaoxing Du,Haiyang Liu,Xi Li,Xueqing Wu,Xiaoting Hua,Ye Feng,Yunsong Yu
DOI: https://doi.org/10.1016/s2666-5247(20)30001-x
IF: 86.208
2020-01-01
The Lancet Microbe
Abstract:Background Although the emergence of the plasmid-mediated colistin resistance gene, mcr-1, caused global concern, little is known about its clinical implications and transmission characteristics over time. We aimed to investigate the clinical relevance of infection with mcr-1-positive Escherichia coli isolates and to investigate long-term plasmid dynamics. Methods We did a multicentre case-control study and molecular epidemiological survey of mcr-1-positive E coli infections. E coli isolates from four hospitals in China in 2008 to 2017 were collected and screened for mcr-1 by PCR and Sanger sequencing. Patients with mcr-1-positive E coli infections and matched controls with mcr-1-negative E coli infections were included in a 1:4 ratio, considering age, sex, living environment, comorbidities, antimicrobials used, and clinical sample type as potential risk factors in a regression model. 28-day mortality was also observed. The genomes of all mcr-1-positive E coli were sequenced to explore their genetic background and map ISApl1 elements. Plasmids carrying mcr-1 were characterised by their resistance profile and incompatibility group. Findings 29 100 isolates were collected across all hospitals and during the study period, 300 (1.03%) of which were mcr-1-positive E coli. The overall proportion of mcr-1-positive isolates significantly increased from 0.42% (1 of 240) in 2008 to 1.39% (66 of 4748; p<0.0001) in 2017. Factors related to health-care contact, including receiving cancer care, indwelling central venous catheter, and hospitalisation in the past 3 months, and some sample types (pus secretion and sputum) were significantly associated with mcr-1-positive E coli infection. 28-day mortality was low in both mcr-1positive (11 [4.4%] of 248 patients) and mcr-1-negative (39 [3.8%] of 1030 patients) groups and did not significantly differ. Although the genetic background of mcr-1-positive E coli was diverse, most of the mcr-1-encoding plasmids occurred in three dominant Inc groups (IncX4, IncI2, and IncHI2). Only the large IncHI2 plasmids conferred multiple resistances and probably integrated with other resistance plasmids. In 205 (68%) of 300 mcr-1-positive E coli isolates, mcr-1 genes lost their capacity for mobilisation because of loss of flanking ISApl1 elements. Interpretation The prevalence of mcr-1-positive E coli infection among patients increased over the study period, although it remained low. Health-care contact was the most probable risk factor. Plasmids are likely to have played a critical role in mcr-1 transmission, rather than clone dissemination and lateral transfer of ISApl1. Our findings underscore the importance of continued surveillance of E coli strains positive for mcr-1 and potentially other resistanceassociated genes, particularly in hospital settings. Copyright (C) 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.